We are live on ! Find out more
FQ

First Quadrant Portfolio holdings

AUM $18M
1-Year Est. Return 24.2%
This Fund
S&P 500
This Quarter Est. Return
+4.86%
1 Year Est. Return
+24.2%
3 Year Est. Return
+90.61%
5 Year Est. Return
+144.39%
10 Year Est. Return
–
AUM
$4.49B
AUM Growth
+$87.2M
Cap. Flow
-$70.7M
Cap. Flow %
-1.57%
Top 10 Hldgs %
16.01%
Holding
859
New
109
Increased
142
Reduced
182
Closed
54

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$26.9M
2
ELV icon
Elevance Health
ELV
+$26.5M
3
GILD icon
Gilead Sciences
GILD
+$20M
4
ZBRA icon
Zebra Technologies
ZBRA
+$18.8M
5
JNJ icon
Johnson & Johnson
JNJ
+$18M

Top Sells

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$27.8M
2
PKG icon
Packaging Corp of America
PKG
+$25.4M
3
AMGN icon
Amgen
AMGN
+$21.4M
4
HSY icon
Hershey
HSY
+$20.5M
5
EIX icon
Edison International
EIX
+$19.8M

Sector Composition

Rank Sector Weight
1 Financials 16.39%
2 Technology 15.39%
3 Healthcare 14.54%
4 Industrials 13.38%
5 Energy 11.78%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GSM icon
501
FerroAtlántica
GSM
$809M
$372K 0.01%
+17,900
New +$360K
MSGS icon
502
Madison Square Garden
MSGS
$9.47B
$368K 0.01%
8,272
+7,851
+1,865% +$309K
SUSS
503
DELISTED
SUSSER HOLDINGS CORPORATION COMMON STOCK
SUSS
$367K 0.01%
4,546
– –
AMP icon
504
Ameriprise Financial
AMP
$49.4B
$360K 0.01%
3,000
– –
LRCX icon
505
Lam Research
LRCX
$339B
$351K 0.01%
52,000
– –
KN icon
506
Knowles
KN
$2.97B
$343K 0.01%
11,150
+6,800
+156% +$206K
RGEN icon
507
Repligen
RGEN
$9.86B
$340K 0.01%
14,900
-48,100
-76% -$856K
KS
508
DELISTED
KapStone Paper and Pack Corp.
KS
$338K 0.01%
10,200
– –
GNW icon
509
Genworth Financial
GNW
$3.78B
$336K 0.01%
19,300
-3,800
-16% -$66.5K
EME icon
510
Emcor
EME
$32.4B
$333K 0.01%
7,486
– –
AKAM icon
511
Akamai
AKAM
$15.1B
$330K 0.01%
5,400
– –
PARA
512
DELISTED
Paramount Global Class B
PARA
$329K 0.01%
5,300
+1,500
+39% +$89.3K
FF icon
513
Future Fuel
FF
$245M
$328K 0.01%
19,800
+14,400
+267% +$262K
RBCAA icon
514
Republic Bancorp
RBCAA
$1.9B
$325K 0.01%
13,700
-3,100
-18% -$72.5K
CMPR icon
515
Cimpress
CMPR
$2.03B
$324K 0.01%
8,000
– –
SBH icon
516
Sally Beauty Holdings
SBH
$1.47B
$324K 0.01%
12,900
+8,300
+180% +$214K
COST icon
517
Costco
COST
$400B
$319K 0.01%
2,772
– –
CHTR icon
518
Charter Communications
CHTR
$16.8B
$317K 0.01%
+2,000
New +$276K
AMT icon
519
American Tower
AMT
$82.8B
$315K 0.01%
3,500
– –
FLWS icon
520
1-800-Flowers.com
FLWS
$197M
$315K 0.01%
54,300
-2,200
-4% -$12.3K
VASC
521
DELISTED
Vascular Solutions Inc
VASC
$315K 0.01%
14,200
– –
DNOW icon
522
DNOW Inc
DNOW
$2.91B
$310K 0.01%
+8,559
New +$295K
RS icon
523
Reliance Steel & Aluminium
RS
$20B
$304K 0.01%
4,127
-36,200
-90% -$2.6M
HOS
524
Hornbeck Offshore Services, Inc.
HOS
$2.89B
$303K 0.01%
11,500
– –
TTEC icon
525
TTEC Holdings
TTEC
$62.6M
$293K 0.01%
10,100
– –
19 20
21
22 23

Similar funds

ICMH
Integrity Capital Management (HK) Central, Hong Kong $19.4M AUM
BC
Blackcrane Capital Bellevue, Washington $16.3M AUM 19.53% 1-Year Est. Return
SCM
SunTx Capital Management Dallas, Texas $21.3M AUM 12.38% 1-Year Est. Return
CFG
Claremont Financial Group Claremont, California $23.4M AUM
AG
Aravt Global New York $11.3M AUM 3.78% 1-Year Est. Return
YEPV
Yorktown Energy Partners V New York $5.41M AUM
WIA
Wealthstreet Investment Advisors Dallas, Texas $3.71M AUM 13.1% 1-Year Est. Return
LSM
Light Sky Macro New York $1.34M AUM

First Quadrant's Q2 2014 Portfolio in Review

As of Q2 2014, First Quadrant held 859 positions worth $4.49B, up 2% from $4.41B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

First Quadrant's Q2 2014 filing shows 109 new, 142 increased, 182 reduced and 54 closed positions. Its largest new stake was Harley-Davidson: 252,500 shares worth $17.6M. The largest sale was Biogen, an estimated $27.8M.

By sector, the portfolio is most concentrated in Financials at 16% of assets, down from 17% a quarter earlier, followed by Technology and Healthcare.

  • First Quadrant's largest Q2 2014 buy was Harley-Davidson: 252,500 shares worth $17.6M.
  • First Quadrant added most to Merck in Q2 2014, an estimated $26.9M increase.
  • First Quadrant's biggest Q2 2014 reduction was Biogen, cutting an estimated $27.8M.
  • First Quadrant fully exited BALLY TECHNOLOGIES, INC. in Q2 2014, selling an estimated $14.7M.
  • First Quadrant's ten largest holdings make up 16% of its $4.49B portfolio in Q2 2014.
  • First Quadrant opened 109 new positions and closed 54 in Q2 2014.
  • First Quadrant's portfolio value rose 2% quarter-over-quarter to $4.49B.

Based on First Quadrant's 13F filing for Q2 2014, filed 31 Jul 2014.